(Q42510385)

English

Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

based on heuristic

inferred from title

author name string

Fangfang Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Yaqing Li

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Meijing Ren

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Xinmin Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Xiaojing Guo

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Ronggang Lang

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Feng Gu

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Li Fu

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

29 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

135

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

459-467

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

A better way for a cancer cell to die

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Calreticulin exposure dictates the immunogenicity of cancer cell death

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Breast cancer subtypes and the risk of local and regional relapse.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2132-3

21 January 2018

Identifiers

10.1007/S10549-012-2132-3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42510385&oldid=2205464134"